Solutions from Process Development to Commercial Manufacturing for mAbs

mAbs - Monoclonal Antibodies

Scalable and Cost-Efficient Single-Use Toolbox for Your mAb Process Platform

By combining our expertise in cell line development and cultivation, media optimization, virus clearance, filtration and polishing of mAbs we provide a complete Toolbox of Solutions which can be adapted in-house or at contract manufacturing organizations.

Sartorius Single-Use Bioreactors and Single-Use Platform

mAbs | Upstream

Speed your Upstream Development and Simplify Manufacturing - From 15 mL to 2000 L

Learn More

mAbs | Downstream

Tackle your Downstream Bottlenecks - From mg to kg of mAbs

Learn More

Intensified Processing

Technologies that enable intensified production throughout the process

Learn More

An Interview with Synthon

In an exclusive interview with Miriam Monge, Head of Segment Marketing mAb at Sartorius, Nienke Vriezen, Synthon’s Director of USP Development and Manufacturing talks about how Sartorius helped Synthon to rapidly implement a flexible single-use facility for the manufacture of monoclonal antibodies.
Founded in 1991, Synthon now employs 1,700 people at nine sites worldwide. The company develops biopharmaceuticals with a focus is on next-generation cancer drugs.

Contact our Experts


Webinar on Sartorius End-to-End, Single-Use Downstream Solution

Learn how Sartorius' new, single-use technologies meet the growing demands of clinical and commercial biopharmaceutical environments.

Watch On-Demand Webinar Now

Consult Our Experts

Consult Our Experts

Explore the Sartorius Platforms for Biomanufacturing

Vaccine Manufacturing, Process Development and Production

Learn More

Regenerative Medicine

Learn More


Learn More